These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11599793)

  • 1. Antibodies to Lassa virus Z protein and nucleoprotein co-occur in human sera from Lassa fever endemic regions.
    Günther S; Kühle O; Rehder D; Odaibo GN; Olaleye DO; Emmerich P; ter Meulen J; Schmitz H
    Med Microbiol Immunol; 2001 Sep; 189(4):225-9. PubMed ID: 11599793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use.
    Ter Meulen J; Koulemou K; Wittekindt T; Windisch K; Strigl S; Conde S; Schmitz H
    J Clin Microbiol; 1998 Nov; 36(11):3143-8. PubMed ID: 9774554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein.
    ter Meulen J; Badusche M; Kuhnt K; Doetze A; Satoguina J; Marti T; Loeliger C; Koulemou K; Koivogui L; Schmitz H; Fleischer B; Hoerauf A
    J Virol; 2000 Mar; 74(5):2186-92. PubMed ID: 10666248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G.
    Gabriel M; Adomeh DI; Ehimuan J; Oyakhilome J; Omomoh EO; Ighodalo Y; Olokor T; Bonney K; Pahlmann M; Emmerich P; Lelke M; Brunotte L; Ölschläger S; Thomé-Bolduan C; Becker-Ziaja B; Busch C; Odia I; Ogbaini-Emovon E; Okokhere PO; Okogbenin SA; Akpede GO; Schmitz H; Asogun DA; Günther S
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006361. PubMed ID: 29596412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.
    Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD
    Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection.
    Barber GN; Clegg JC; Lloyd G
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():19-28. PubMed ID: 2406367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.
    Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF
    Virol J; 2010 Oct; 7():279. PubMed ID: 20961433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Common CD8
    Sakabe S; Hartnett JN; Ngo N; Goba A; Momoh M; Sandi JD; Kanneh L; Cubitt B; Garcia SD; Ware BC; Kotliar D; Robles-Sikisaka R; Gangavarapu K; Branco LM; Eromon P; Odia I; Ogbaini-Emovon E; Folarin O; Okogbenin S; Okokhere PO; Happi C; Sabeti PC; Andersen KG; Garry RF; de la Torre JC; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein.
    Djavani M; Yin C; Xia L; Lukashevich IS; Pauza CD; Salvato MS
    Vaccine; 2000 Feb; 18(15):1543-54. PubMed ID: 10618553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serological evidence of Lassa virus circulation in the Republic of Guinea].
    Lukashevich IS; Lukashevich VD; Vladyko AS; Diallo MS; Ba MA; Silla A
    Vopr Virusol; 1993; 38(1):24-8. PubMed ID: 8073741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.
    Branco LM; Grove JN; Moses LM; Goba A; Fullah M; Momoh M; Schoepp RJ; Bausch DG; Garry RF
    Virol J; 2010 Nov; 7():306. PubMed ID: 21062490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-specific antibody response to Lassa virus in the local population of west Africa.
    Emmerich P; Günther S; Schmitz H
    J Clin Virol; 2008 May; 42(1):40-4. PubMed ID: 18164653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa.
    Emmerich P; Thome-Bolduan C; Drosten C; Gunther S; Ban E; Sawinsky I; Schmitz H
    J Clin Virol; 2006 Dec; 37(4):277-81. PubMed ID: 16996789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen.
    Lukashevich IS; Clegg JC; Sidibe K
    J Med Virol; 1993 Jul; 40(3):210-7. PubMed ID: 8355019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenic and protective characteristics of recombinant Lassa virus NP protein].
    Ignat'ev GM
    Vopr Virusol; 2002; 47(2):28-31. PubMed ID: 12046464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
    Heinrich ML; Boisen ML; Nelson DKS; Bush DJ; Cross RW; Koval AP; Hoffmann AR; Beddingfield BJ; Hastie KM; Rowland MM; Aimukanova I; Koval S; Lathigra R; Borisevich V; Momoh M; Sandi JD; Goba A; Odia L; Baimba F; Aiyepada JO; Ebo B; Eromon P; Ugwu C; Folarin O; Olumade T; Onyechi MN; Etafo J; Adeyemi R; Ella EE; Aminu M; Gomerep SS; Eke MA; Ogunsanya O; Akpede GO; Asogun DO; Okogbenin SA; Okokhere PO; Holst J; Shaffer JG; Schieffelin JS; Geisbert TW; Saphire EO; Happi CT; Grant DS; Garry RF; Branco LM
    Sci Rep; 2020 Sep; 10(1):16030. PubMed ID: 32994446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins.
    Groen J; van den Hoogen BG; Burghoorn-Maas CP; Fooks AR; Burton J; Clegg CJ; Zeller H; Osterhaus AD
    Microbes Infect; 2003 Apr; 5(5):379-85. PubMed ID: 12737993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.
    Saijo M; Georges-Courbot MC; Marianneau P; Romanowski V; Fukushi S; Mizutani T; Georges AJ; Kurata T; Kurane I; Morikawa S
    Clin Vaccine Immunol; 2007 Sep; 14(9):1182-9. PubMed ID: 17634509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Antibody and Antigen for Lassa Virus Nucleoprotein in Monkeys from Southern Nigeria.
    Ogunro BN; Olugasa BO; Kayode A; Ishola OO; Kolawole ON; Odigie EA; Happi C
    J Epidemiol Glob Health; 2019 Jun; 9(2):125-127. PubMed ID: 31241870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP).
    Eichler R; Strecker T; Kolesnikova L; ter Meulen J; Weissenhorn W; Becker S; Klenk HD; Garten W; Lenz O
    Virus Res; 2004 Mar; 100(2):249-55. PubMed ID: 15019244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.